Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: GIDEON observational study
Abstract
Treatment approaches for hepatocellular carcinoma (HCC) vary across countries, but these differences and their potential impact on outcomes have not been comprehensively assessed. Data from the multinational GIDEON (Global Investigation of therapeutic DEcisions in HCC and Of its treatment with sorafeNib) registry evaluated differences in patient characteristics, practice patterns and outcomes in HCC across geographical regions in patients who...
Paper Details
Title
Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: GIDEON observational study
Published Date
Apr 1, 2016
Journal
Volume
36
Issue
8
Pages
1196 - 1205
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History